Alfresa Holdings Corporation (TYO:2784)

Market Cap	441.76B
Revenue (ttm)	3.03T
Net Income (ttm)	24.85B
Shares Out	181.72M
EPS (ttm)	135.67
PE Ratio	17.92
Forward PE	13.77
Dividend	68.00 (2.77%)
Ex-Dividend Date	Mar 30, 2026

Volume	192,400
Average Volume	279,985
Open	2,464.00
Previous Close	2,458.00
Day's Range	2,426.50 - 2,465.00
52-Week Range	1,897.00 - 2,473.50
Beta	-0.35
RSI	56.13
Earnings Date	Feb 10, 2026

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract dis...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2003
• Employees: 12,452
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2784

Financial Performance

In 2024, Alfresa Holdings's revenue was 2.96 trillion, an increase of 3.59% compared to the previous year's 2.86 trillion. Earnings were 27.39 billion, a decrease of -7.34%.